Perinatal hypoxic-ischemic brain injury affects the glutamatergic signal transduction coupled with neuronal ADP-ribosyl cyclase activity

Bulletin of Experimental Biology and Medicine

Volumn 150, Issue 5, 2011, Pages 583-586

  Salmina, A B ^a,b   Okuneva, O S ^a,b   Mikhutkina, S V ^a,b   Malinovskaya, N A ^a,b   Morgun, A V ^b   Zykova, L D ^c   Yudin, G V ^a   Laletin, D V ^a   Fursov, M A ^a   Frolova, O V ^a   Tagaeva, G A ^a   Bolshakova, E V ^a,b  

^a Course of Medical Pharmaceutical and Toxicological Chemistry ^*  (Russian Federation)

^b Institute of Molecular Medicine and Pathobiochemistry   (Russian Federation)

^c KRASNOYARSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

ADP ribosyl cyclase; CD38; Cerebellar granular cells; Glutamatergic signaling; Perinatal brain injury

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD38 ANTIGEN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GRANULAR CELL; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD38; CEREBELLUM; EXCITATORY AMINO ACID AGONISTS; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; MEMBRANE GLYCOPROTEINS; N-METHYLASPARTATE; NEURONS; RATS; RECEPTORS, IONOTROPIC GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79959259528     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-011-1196-0     Document Type: Article

References (15)

1. S. P. Alexander, A. Mathie, and J. A. Peters, Br. J. Pharmacol., 153, Suppl. 2, S1-S209 (2008).
2. A. Boldyrev, E. Bulygina, D. Carpenter, and W. Schoner, J. Mol. Neurosci., 21, No. 3, 213-222 (2003).
3. A. De Flora, L. Guida, L. Franco, et al., Biochem. J., 320, Pt. 2, 665-671 (1996).
4. Y. Duan, R. A. Gross, and S. S. Sheu, J. Physiol., 585, Pt. 3, 741-758 (2007).
5. R. M. Graeff, T. F. Walseth, K. Fryxell, et al., J. Biol. Chem., 269, No. 48, 30,260-30,267 (1994).
6. H. Higashida, A. B. Salmina, R. Y. Olovyannikova, et al., Neurochem. Int., 51, Nos. 2-4, 192-199 (2007).
7. L. V. Kalia, S. K. Kalia, and M. W. Salter, Lancet Neurol., 7, No. 8, 742-755 (2008).
8. D. Makarewicz, M. Duszczyk, R. Gadamski, et al., Neurochem. Int., 48, Nos. 6-7, 485-490 (2006).
9. C. Montoliu, M. Liansola, C. Cucarella, et al., J. Pharmacol. Exp. Ther., 281, No. 2, 643-647 (1997).
10. H. Morikawa, K. Khodakhah, and J. T. Williams, J. Neurosci., 23, No. 1, 149-157 (2003).
11. J. Perroy, F. Raynaud, V. Homburger, et al., J. Biol. Chem., 283, No. 11, 6799-6805 (2008).
12. J. E. Rice, R. C. Vannucci, and J. B. Brierley, Ann. Neurol., 9, No. 2, 131-141 (1981).
13. P. B. Simpson, S. R. Nahorski, and R. A. Challiss, J. Neurochem., 67, No. 1, 364-373 (1996).
14. J. D. Sinor, S. Du, S. Venneti, et al., J. Neurosci., 20, No. 23, 8831-8837 (2000).
15. R. C. Vanucci, R. M. Brucklacher, and S. J. Vanucci, Brain Res. Dev. Brain Res., 126, No. 1, 117-120 (2001).